ERBB2 and breast cancer: No significant difference was observed in those parameters of histological type, histological grade, estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER-2) comparing N− group with N+ group in BC patients (p > 0.05), and the results were listed in Table 1.